Kynurenine emerges from the shadows - Current knowledge on its fate and function.

Published on Apr 5, 2021in Pharmacology & Therapeutics12.31
路 DOI :10.1016/J.PHARMTHERA.2021.107845
Marta Marszalek-Grabska9
Estimated H-index: 9
(Medical University of Lublin),
Katarzyna Walczak10
Estimated H-index: 10
(Medical University of Lublin)
+ 4 AuthorsWaldemar A. Turski50
Estimated H-index: 50
(Medical University of Lublin)
Sources
Abstract
Kynurenine (KYN), a main metabolite of tryptophan in mammals, is a direct precursor of kynurenic acid, anthranilic acid and 3-hydroxykynurenine. Under physiological conditions, KYN is produced endogenously mainly in the liver by tryptophan 2,3-dioxygenase (TDO). Tumorigenesis and inflammatory conditions increase the activity of another KYN synthetizing enzyme, indoleamine 2,3-dioxygenase (IDO). However, knowledge about the exogenous sources and the fate of KYN in mammals is still limited. While most papers deal with the contribution of KYN to pathologies of the central nervous system, its role in the periphery has almost been ignored. KYN is a ligand for the aryl hydrocarbon receptor (AhR). As a receptor for KYN and its downstream metabolites, AhR is involved in several physiological and pathological conditions, including inflammation and carcinogenesis. Recent studies have shown that KYN suppresses immune response and is strongly involved in the process of carcinogenesis and tumour metastasis. Thus, inhibition of activity of the enzymes responsible for KYN synthesis, TDO, IDO or genetic manipulation leading to reduction of KYN synthesis, could be considered as innovative strategies for improving the efficacy of immunotherapy. Surprisingly, however, genetic or pharmacological approaches for reducing tryptophan catabolism to KYN do not necessarily result in decrease of KYN level in the main circulation. This review aims to summarize the current knowledge of KYN fate and function and to emphasize its importance for vital physiological and pathological processes.
馃摉 Papers frequently viewed together
References389
Newest
#1Mohammad Al-Mahdi Al-Karagholi (UCPH: University of Copenhagen)H-Index: 10
#2Jakob M酶ller Hansen (UCPH: University of Copenhagen)H-Index: 24
Last. Messoud Ashina (UCPH: University of Copenhagen)H-Index: 66
view all 9 authors...
The kynurenine pathway (KP) is the main path for tryptophan metabolism, and it represents a multitude of potential sites for drug discovery in neuroscience, including pain, stroke, and epilepsy. L-kynurenine (LKYN), the first active metabolite in the pathway, emerges to be a prodrug targeting glutamate receptors. The safety, tolerability, pharmacokinetics, and pharmacodynamics of LKYN in humans have not been previously investigated. In an open-label, single ascending dose study, six participants...
Source
Abstract Drug use poses a serious threat to health systems throughout the world and the number of consumers rises relentlessly every year. The kynurenine pathway, main pathway of tryptophan degradation, has drawn interest in this field due to its relationship with addictive behaviour. Recently it has been confirmed that modulation of kynurenine metabolism at certain stages of the pathway can reduce, prevent or abolish drug seeking-like behaviours in studies with several different drugs. In this ...
Source
#1Yuanyuan Deng (Nanjing Medical University)H-Index: 1
#2Manfei Zhou (Nanjing Medical University)H-Index: 1
Last. Rong Gao (Nanjing Medical University)H-Index: 14
view all 9 authors...
Emerging evidence suggests that the gut microbiota may interact with the host brain and play pivotal roles in the pathogenesis of neuropsychiatric disorders. However, the mechanism underlying reciprocal interactions along the microbiota-gut-brain axis in depression remains unclear. In this study, a murine model of chronic restraint stress (CRS) was established to investigate the metabolic signaling of tryptophan (Trp) neurotransmission at the intestinal and central levels in depression. The resu...
Source
#1Fan Deng (Southern Medical University)H-Index: 2
#2Bing-Cheng Zhao (Southern Medical University)H-Index: 8
Last. Ke-Xuan Liu (Southern Medical University)H-Index: 9
view all 11 authors...
Ferroptosis, a new type of cell death has been found to aggravate intestinal ischemia/reperfusion (I/R) injury. However, little is known about the changes of gut microbiota and metabolites in intes...
Source
#1Ada Trepci (KI: Karolinska Institutet)H-Index: 4
#2Sophie Imbeault (KI: Karolinska Institutet)H-Index: 4
Last. Sigitas Kamandulis (Lithuanian Sports University)H-Index: 18
view all 13 authors...
The kynurenine pathway of tryptophan degradation produces several neuroactive metabolites suggested to be involved in a wide variety of diseases and disorders, however, technical challenges in reli...
Source
Neurodegenerative diseases are multifactorial, initiated by a series of the causative complex which develops into a certain clinical picture. The pathogenesis and disease course vary from patient to patient. Thus, it should be likewise to the treatment. Peripheral biomarkers are to play a central role for tailoring a personalized therapeutic plan for patients who suffered from neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, among others. Never...
Source
#1Ana Dol拧ak (University of Ljubljana)H-Index: 3
#2Stanislav Gobec (University of Ljubljana)H-Index: 40
Last. Matej Sova (University of Ljubljana)H-Index: 17
view all 3 authors...
Conversion of tryptophan to N-formylkynurenine is the first and rate-limiting step of the tryptophan metabolic pathway (i.e., the kynurenine pathway). This conversion is catalyzed by three enzyme isoforms: indoleamine 2,3-dioxygenase 1 (IDO1), indoleamine 2,3-dioxygenase 2 (IDO2), and tryptophan 2,3-dioxygenase (TDO). As this pathway generates numerous metabolites that are involved in various pathological conditions, IDOs and TDO represent important targets for therapeutic intervention. This pat...
Source
#1Il-Young Jang (UOU: University of Ulsan)H-Index: 13
#2Jin Hoon Park (UOU: University of Ulsan)H-Index: 15
Last. Beom-Jun Kim (UOU: University of Ulsan)H-Index: 27
view all 10 authors...
Despite the accumulating evidence from in vitro and animal experiments supporting the role of kynurenine (a tryptophan metabolite) in a number of degenerative age-related changes, the relationship between kynurenine and frailty in older adults is not well understood. We collected blood samples from 73 participants who underwent a comprehensive geriatric assessment, measuring kynurenine levels using liquid chromatography-tandem mass spectrometry. We assessed the phenotypic frailty and the deficit...
Source
Abstract Indoleamine-2,3-dioxygenase 1 (IDO1) and tryptophan-2,3-dioxygenase 2 (TDO2) degrade tryptophan (Trp) to kynurenine (Kyn), and these enzymes have promise as therapeutic targets. A comprehensive characterization of potential safety liabilities of IDO1 and TDO2 inhibitors using knockout (KO) mice has not been assessed, nor has the dual Ido1/Tdo2 KO been reported. Here we characterized male and female mice with KOs for Ido1, Tdo2, and Ido1/Tdo2 and compared findings to the wild type (WT) m...
Source
#1Katarzyna Walczak (Medical University of Lublin)H-Index: 10
#2Ewa Langner (Medical University of Lublin)H-Index: 16
Last. Tomasz Plech (Medical University of Lublin)H-Index: 17
view all 7 authors...
Tryptophan metabolites: kynurenine (KYN), kynurenic acid (KYNA) and 6-formylindolo[3,2-b]carbazole (FICZ) are considered aryl hydrocarbon receptor (AhR) ligands. AhR is mainly expressed in barrier tissues, including skin, and is involved in various physiological and pathological processes in skin. We studied the effect of KYN, KYNA and FICZ on melanocyte and melanoma A375 and RPMI7951 cell toxicity, proliferation and cell death. KYN and FICZ inhibited DNA synthesis in both melanoma cell lines, b...
Source
Cited By2
Newest
In recent years, tryptophan metabolism via the kynurenine pathway has become one of the most active research areas thanks to its involvement in a variety of physiological processes, especially in conditions associated with immune dysfunction, central nervous system disorders, autoimmunity, infection, diabetes, and cancer. The kynurenine pathway generates several metabolites with immunosuppressive functions or neuroprotective, antioxidant, or toxic properties. An increasing body of work on this t...
Source
#1Maryana Stephany Ferreira Branquinho (USP: University of S茫o Paulo)H-Index: 2
#2Maysa Braga Barros Silva (USP: University of S茫o Paulo)H-Index: 2
Last. Ana Campa (USP: University of S茫o Paulo)H-Index: 21
view all 8 authors...
Kynurenine (KYN), the most abundant metabolite of tryptophan, is classically associated with immune tolerance and tumor immune escape. In the last years, KYN is in the spotlight in other biological processes. Here, we showed that KYN inhibited tyrosinase expression and melanin content in primary human melanocyte and keratinocyte co-cultures. Furthermore, KYN decreased melanosome content in a 3D human skin reconstruction model. In these experiments, we used tyrosine + NH4 Cl to induce pigmentatio...
Source
#1Niklas Joisten (Technical University of Dortmund)H-Index: 9
#2Jorge L. Ruas (KI: Karolinska Institutet)H-Index: 32
Last. Philipp Zimmer (Technical University of Dortmund)H-Index: 19
view all 5 authors...
The kynurenine (KYN) pathway (KP) of tryptophan (TRP) metabolism is dysregulated in inflammation-driven pathologies including oncological and brain diseases [e.g., multiple sclerosis (MS), depression] and thus is a promising therapeutic target. Both pathological and compensatory mechanisms underlie disease-associated KP activation. There is growing evidence for bioenergetic roles of certain KP metabolites such as kynurenic acid (KA), or quinolinic acid (QA) as an NAD+ precursor, which may explai...
Source
#1Duygu Eryavuz Onmaz (Sel莽uk University)H-Index: 1
#2Abdullah Sivrikaya (Sel莽uk University)H-Index: 9
Last. Dilek Tezcan (Sel莽uk University)
view all 9 authors...
BACKGROUND Various studies reported that increased proinflammatory cytokines in patients with ankylosing spondylitis (AS). Proinflammatory cytokines can affect the expression of various kynurenine pathway enzymes and therefore lead to metabolic changes that can affect the inflammatory response and immunity. Our aim was to measure serum levels of kynurenine pathway metabolites in patients with AS. METHODS The study included 85 patients with AS and 50 healthy volunteers. Serum tryptophan, kynureni...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.